Pursuit Vascular Raises $1.6M in Debt Funding

According to a filing with the S.E.C., Pursuit Vascular, a Maple Grove, MN-based developer of preventive medical devices for catheter-related bloodstream infections, raised $1.6m in funding.

The backers of the debt round were not disclosed.

Led by President & CEO Doug Killion, Pursuit Vascular is developing a family of products based on its patented ClearGuard™ platform technology, which has been shown to be safe and effective for reducing microbial colonization in hemodialysis catheter hubs.
The first product targets infections associated with hemodialysis catheters.



Join the discussion